Company intelligence / Profile preview

A5 Laboratories

Las Vegas, Nevada, USA

Ownership: Private
Development stage: Other

Overview

A5 Laboratories, Inc. was a development-stage pharmaceutical company primarily focused on the development, manufacturing, and marketing of generic pharmaceutical products. The company aimed to identify and commercialize niche generic versions of off-patent drugs, often utilizing specialized drug delivery technologies to enhance efficacy. Based in Nevada, A5 Laboratories sought to build a portfolio of affordable medications across various therapeutic areas. However, the company has since become inactive, with its public filings and operations ceasing several years ago.

Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on A5 Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on A5 Laboratories.

Explore the full profile